Founded in 2001, Biofrontier Partners is a California-based private equity company that also provides research and analysis solutions.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 6, 2006
Perlegen Sciences
|
Series D | $50M | Biotechnology | — |
Jul 16, 2005
BioTrove
|
Series B | $5M | Biotechnology | — |
Feb 28, 2005
Perlegen Sciences
|
Series D | $74M | Biotechnology | — |
Jan 29, 2004
BioTrove
|
Series B | $10.90M | Biotechnology | — |
Mar 17, 2003
CellZome
|
Series C | €30M | Biotechnology | — |
Biofrontier Partners has had 5 exits. Biofrontier Partners most notable exits include CellZome , BioTrove
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 15, 2012 | CellZome | M&A | Biotechnology | Detail |
Nov 10, 2009 | BioTrove | M&A | Biotechnology | Detail |
Mar 19, 2008 | CardioNet | IPO | Biotechnology | Detail |
May 12, 2005 | Salmedix | M&A | Biotechnology | Detail |
Oct 4, 2002 | AnGes | IPO | Biopharma | Detail |